<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03522974</url>
  </required_header>
  <id_info>
    <org_study_id>Strawberry Study</org_study_id>
    <nct_id>NCT03522974</nct_id>
  </id_info>
  <brief_title>Effects of Freeze Dried Strawberry Powder Supplementation on Cardiovascular Risk Factors and Gut Microbiome</brief_title>
  <official_title>Effects of Freeze Dried Strawberry Powder Supplementation on Vascular Function, Blood Markers of Cardiovascular Risk, and the Gut Microbiome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arizona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dietary interventions designed to promote health by increasing the consumption of particular
      health-promoting foods (e.g., strawberries) generally target blood pressure and LDL-C;
      however, CVD risk reduction may also be achieved via changes in emerging endpoints such as
      the gut microbiome. Previous research suggests that strawberries have the potential to reduce
      LDL-C, but it remains unclear whether there is a dose-response relationship. Moreover, few
      studies have evaluated effects on vascular health or characterized changes in the gut
      microbiome following daily strawberry consumption. Additionally, previous studies have
      largely been conducted among Caucasian populations. Given the demographics of the US, it is
      important to evaluate effects in study populations that include ethnicities that may have
      higher risk of type 2 diabetes and/or other CVD risk factors, such as Hispanics. This study
      aims to examine the effects of 4 weeks of supplementation with two doses of freeze dried
      strawberry powder (low dose: 13 g/d and high dose: 40 g/d) on: 1) LDL-C and blood pressure;
      2) gut microbiome profile; and 3) other CVD and type 2 diabetes risk factors, including
      glucose, insulin, and inflammatory markers. Overweight (BMI 25-36 kg/m2) but otherwise
      healthy adults with moderately elevated LDL-C (&gt;3.0 mmol/L) and/or prehypertension
      (120-159/80-99 mm Hg) will be enrolled. This will optimize the potential for observing
      significant benefits on these outcomes. 50 eligible participants will be recruited with the
      expectation that at least 40 will complete the study. The placebo-controlled, crossover study
      design will allow for a direct comparison of dose-response within the same participant. The
      investigators anticipate that the bioactive components of strawberries will reduce LDL-C and
      blood pressure, and modify the gut microbiome, with greater changes on the high dose. There
      is preliminary evidence that polyphenol-rich foods can modify gut microbiota profiles, but
      this would be the first study to characterize the effects of daily strawberry consumption.
      The investigators are uniquely placed at the University of Arizona to enroll a larger
      percentage of Hispanic participants, who are often under-represented in clinical nutritional
      research. Results from the proposed study will improve understanding of how strawberries
      might promote health, and could provide further support for the incorporation of whole freeze
      dried fruit in dietary guidelines.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 7, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LDL-C/non-HDL-C</measure>
    <time_frame>4-6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Brachial and central blood pressure</measure>
    <time_frame>4-6- weeks</time_frame>
    <description>systolic and diastolic blood pressures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulse Wave Velocity (PWV)</measure>
    <time_frame>4-6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Augmentation Index</measure>
    <time_frame>4-6 weeks</time_frame>
    <description>augmentation index corrected for heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other lipids and lipoproteins</measure>
    <time_frame>4-6 weeks</time_frame>
    <description>HDL-C, total cholesterol, and triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>4-6 weeks</time_frame>
    <description>fasting glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>4-6 weeks</time_frame>
    <description>fasting insulin</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Gut microbiome</measure>
    <time_frame>4-6 weeks</time_frame>
    <description>Composition of the gut microbial community measured by high-throughput 16S rRNA sequencing</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cardiovascular Risk Factor</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>40 g/d placebo powder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Strawberry powder (high dose)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>40 g/d freeze dried strawberry powder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Strawberry powder (low dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>13 g/d freeze dried strawberry powder</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Strawberry powder</intervention_name>
    <description>Freeze dried strawberry powder</description>
    <arm_group_label>Strawberry powder (high dose)</arm_group_label>
    <arm_group_label>Strawberry powder (low dose)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo powder</intervention_name>
    <description>40 g/d placebo powder matched for taste and appearance</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least one of the following:

               -  LDL-C above 3.0 mmol/L (116 mg/dL)

               -  Systolic blood pressure of 120-159 mmHg

               -  Diastolic blood pressure of 80-99 mmHg

          -  Total cholesterol below 6.2 mmol/L (240 mg/dL)

          -  Triglycerides below 350 mg/dL

        Exclusion Criteria:

          -  Allergies to strawberries

          -  History of CVD, Stage II hypertension (BP ≥ 160/100 mmHg), kidney disease, diabetes,
             or inflammatory diseases such as GI disorders and rheumatoid arthritis

          -  Use of medications/supplements for elevated lipids, blood pressure, or glucose

          -  Chronic use of non-steroidal anti-inflammatory or immunosuppressant drugs

          -  Conditions requiring chronic use of steroids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chesney Richter, PhD</last_name>
    <phone>520-621-5382</phone>
    <email>richterck@email.arizona.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ann Skulas-Ray, PhD</last_name>
    <phone>520-621-2084</phone>
    <email>skulasray@email.arizona.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85721</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Skulas-Ray</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>U.S. Department of Health and Human Services and U.S. Department of Agriculture, 2015-2020 Dietary Guidelines for Americans, 2015.</citation>
  </reference>
  <reference>
    <citation>Basu A, Betts NM, Nguyen A, Newman ED, Fu D, Lyons TJ. Freeze-dried strawberries lower serum cholesterol and lipid peroxidation in adults with abdominal adiposity and elevated serum lipids. J Nutr. 2014 Jun;144(6):830-7. doi: 10.3945/jn.113.188169. Epub 2014 Mar 26.</citation>
    <PMID>24670970</PMID>
  </reference>
  <reference>
    <citation>Jennings A, Welch AA, Fairweather-Tait SJ, Kay C, Minihane AM, Chowienczyk P, Jiang B, Cecelja M, Spector T, Macgregor A, Cassidy A. Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am J Clin Nutr. 2012 Oct;96(4):781-8. Epub 2012 Aug 22.</citation>
    <PMID>22914551</PMID>
  </reference>
  <reference>
    <citation>Tuohy KM, Conterno L, Gasperotti M, Viola R. Up-regulating the human intestinal microbiome using whole plant foods, polyphenols, and/or fiber. J Agric Food Chem. 2012 Sep 12;60(36):8776-82. doi: 10.1021/jf2053959. Epub 2012 Jun 12. Review.</citation>
    <PMID>22607578</PMID>
  </reference>
  <reference>
    <citation>Richter CK, Skulas-Ray AC, Gaugler TL, Lambert JD, Proctor DN, Kris-Etherton PM. Incorporating freeze-dried strawberry powder into a high-fat meal does not alter postprandial vascular function or blood markers of cardiovascular disease risk: a randomized controlled trial. Am J Clin Nutr. 2017 Feb;105(2):313-322. doi: 10.3945/ajcn.116.141804. Epub 2016 Dec 21.</citation>
    <PMID>28003205</PMID>
  </reference>
  <reference>
    <citation>Burton-Freeman B, Linares A, Hyson D, Kappagoda T. Strawberry modulates LDL oxidation and postprandial lipemia in response to high-fat meal in overweight hyperlipidemic men and women. J Am Coll Nutr. 2010 Feb;29(1):46-54.</citation>
    <PMID>20595645</PMID>
  </reference>
  <reference>
    <citation>Zunino SJ, Parelman MA, Freytag TL, Stephensen CB, Kelley DS, Mackey BE, Woodhouse LR, Bonnel EL. Effects of dietary strawberry powder on blood lipids and inflammatory markers in obese human subjects. Br J Nutr. 2012 Sep;108(5):900-9. doi: 10.1017/S0007114511006027. Epub 2011 Nov 9.</citation>
    <PMID>22068016</PMID>
  </reference>
  <reference>
    <citation>Park E, Edirisinghe I, Wei H, Vijayakumar LP, Banaszewski K, Cappozzo JC, Burton-Freeman B. A dose-response evaluation of freeze-dried strawberries independent of fiber content on metabolic indices in abdominally obese individuals with insulin resistance in a randomized, single-blinded, diet-controlled crossover trial. Mol Nutr Food Res. 2016 May;60(5):1099-109. doi: 10.1002/mnfr.201500845. Epub 2016 Mar 29.</citation>
    <PMID>26842771</PMID>
  </reference>
  <reference>
    <citation>Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P, Mattila P, Jula A. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr. 2008 Feb;87(2):323-31.</citation>
    <PMID>18258621</PMID>
  </reference>
  <reference>
    <citation>Vendrame S, Guglielmetti S, Riso P, Arioli S, Klimis-Zacas D, Porrini M. Six-week consumption of a wild blueberry powder drink increases bifidobacteria in the human gut. J Agric Food Chem. 2011 Dec 28;59(24):12815-20. doi: 10.1021/jf2028686. Epub 2011 Nov 18.</citation>
    <PMID>22060186</PMID>
  </reference>
  <reference>
    <citation>Espín JC, Larrosa M, García-Conesa MT, Tomás-Barberán F. Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far. Evid Based Complement Alternat Med. 2013;2013:270418. doi: 10.1155/2013/270418. Epub 2013 May 28.</citation>
    <PMID>23781257</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2018</study_first_submitted>
  <study_first_submitted_qc>April 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2018</study_first_posted>
  <last_update_submitted>May 11, 2018</last_update_submitted>
  <last_update_submitted_qc>May 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Arizona</investigator_affiliation>
    <investigator_full_name>Ann Skulas-Ray</investigator_full_name>
    <investigator_title>Assistant Professor of Nutritional Sciences</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

